Etrasimod
Specifications
1206123-37-6CAS Number
2-[(3R)-7-[[4-cyclopentyl-3-(trifluoromethyl)phenyl]methoxy]-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]acetic acidIUPAC Name
C26H26F3NO3Chemical Formula
457.5 g/molMolecular Weight
Etrasimod; 1206123-37-6; APD334; APD-334; etrasimodum; 6WH8495MMH; APD-334(FREE ACID); 2-[(3R)-7-[[4-cyclopentyl-3-(trifluoromethyl)phenyl]methoxy]-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]acetic acid; (R)-2-(7-(4-Cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta(b)indol-3-yl) acetic acid; 2-((3R)-7-((4-cyclopentyl-3-(trifluoromethyl)phenyl)methoxy)-1,2,3,4-tetrahydrocyclopenta(b)indol-3-yl)acetic acid; RefChem:139296; 2-((3R)-7-((4-cyclopentyl-3-(trifluoromethyl)phenyl)methoxy)-1H,2H,3H,4H-cyclopenta(b)indol-3-yl)acetic acid; (R)-2-(7-((4-cyclopentyl-3-(trifluoromethyl)benzyl)oxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid; Etrasimod [USAN]; Etrasimod(APD334); CHEMBL3358920; Etrasimod (USAN); [(3R)-7-{[4-Cyclopentyl-3-(trifluoromethyl)phenyl]methoxy}-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]acetic acid; (R)-2-[7-[[4-Cyclopentyl-3-(trifluoromethyl)benzyl]oxy]-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]acetic Acid; MFCD28502134; 1206123-37-6 (free base); ETRASIMOD [INN]; ETRASIMOD [WHO-DD]; UNII-6WH8495MMH; GTPL9331; orb1296117; SCHEMBL1919311; SCHEMBL29359174; C26H26F3NO3; APD 334; CHEBI:229230; MVGWUTBTXDYMND-QGZVFWFLSA-N; DTXSID201358909; GLXC-10642; EX-A1633; BDBM50041691; AKOS032944972; APD334-003; compound 4 [PMID: 25516790]; CS-6181; DB14766; AC-35444; DA-63317; FC158571; HY-12789; MS-28349; SY326202; D10930; F798898; Q27265630; (R)-2-(7-(4-Cyclopentyl- 3- (trifluoromethyl) benzyloxy) - 1, 2, 3, 4- tetrahydrocyclopenta [b] indol- 3- yl) acetic acid; (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid; CYCLOPENT(B)INDOLE-3-ACETIC ACID, 7-((4-CYCLOPENTYL-3-(TRIFLUOROMETHYL)PHENYL)METHOXY)-1,2,3,4-TETRAHYDRO-, (3R)-Synonyms
